Future study of colorectal cancer will refine our understanding of the genetics of the disease. This in turn will lead to earlier identification and treatment of high-risk persons. The future may possibly bring the use of genetic interventions to interrupt the adenoma-carcinoma sequence.
Increased awareness of colorectal cancer by the public and by private insurers, government agencies, and medical personnel will result in better use of available screening techniques. Development of preventive drug strategies against colorectal cancer, particularly with drugs that reduce polyp formation or prevent polyp progression to cancer, promises to be a fruitful field of endeavor.
There is ample reason to expect refinement of diagnostic and staging tests for the disease, perfection of surgical and nonsurgical techniques for treatment of large bowel cancer and its complications, and improving chemotherapeutic treatment by means of more effective and less toxic drugs.